Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

In vitro analysis of drugs that improve hyperglycemia-induced blood-brain barrier dysfunction.

Kayano R, Morofuji Y, Nakagawa S, Fukuda S, Watanabe D, Ozawa H, Niwa M, Matsuo T.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1885-1890. doi: 10.1016/j.bbrc.2018.07.131. Epub 2018 Jul 29.

PMID:
30060956
2.

Lysophosphatidic acid receptor, LPA6, regulates endothelial blood-brain barrier function: Implication for hepatic encephalopathy.

Masago K, Kihara Y, Yanagida K, Hamano F, Nakagawa S, Niwa M, Shimizu T.

Biochem Biophys Res Commun. 2018 Jul 2;501(4):1048-1054. doi: 10.1016/j.bbrc.2018.05.106. Epub 2018 May 24.

PMID:
29778535
3.

Association between Mastication, the Hippocampus, and the HPA Axis: A Comprehensive Review.

Azuma K, Zhou Q, Niwa M, Kubo KY.

Int J Mol Sci. 2017 Aug 3;18(8). pii: E1687. doi: 10.3390/ijms18081687. Review.

4.

Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions.

Fukuda S, Nakagawa S, Tatsumi R, Morofuji Y, Takeshita T, Hayashi K, Tanaka K, Matsuo T, Niwa M.

J Mol Neurosci. 2016 Jun;59(2):211-9. doi: 10.1007/s12031-015-0696-1. Epub 2015 Dec 11.

PMID:
26659380
5.

Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model.

Xu L, Dan M, Shao A, Cheng X, Zhang C, Yokel RA, Takemura T, Hanagata N, Niwa M, Watanabe D.

Int J Nanomedicine. 2015 Sep 29;10:6105-18. doi: 10.2147/IJN.S85265. eCollection 2015.

6.

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

So G, Nakagawa S, Morofuji Y, Hiu T, Hayashi K, Tanaka K, Suyama K, Deli MA, Nagata I, Matsuo T, Niwa M.

Cell Mol Neurobiol. 2015 May;35(4):563-72. doi: 10.1007/s10571-014-0152-8. Epub 2014 Dec 30.

PMID:
25547389
7.

Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease.

Nakamura T, Satoh K, Fukuda T, Kinoshita I, Nishiura Y, Nagasato K, Yamauchi A, Kataoka Y, Nakamura T, Sasaki H, Kumagai K, Niwa M, Noguchi M, Nakamura H, Nishida N, Kawakami A.

J Neurovirol. 2014 Jun;20(3):269-77. doi: 10.1007/s13365-014-0244-8. Epub 2014 Mar 27.

PMID:
24671717
8.

[Isolation of cells constituting the blood-brain barrier and reconstruction of the in vitro BBB model].

Nakagawa S, Niwa M.

Nihon Yakurigaku Zasshi. 2014 Mar;143(3):137-43. Review. Japanese. No abstract available.

PMID:
24614637
9.

Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.

Takeshita T, Nakagawa S, Tatsumi R, So G, Hayashi K, Tanaka K, Deli MA, Nagata I, Niwa M.

Mol Cell Neurosci. 2014 May;60:1-9. doi: 10.1016/j.mcn.2014.01.006. Epub 2014 Jan 25.

PMID:
24472843
10.

Hepatocyte growth factor enhances the barrier function in primary cultures of rat brain microvascular endothelial cells.

Yamada N, Nakagawa S, Horai S, Tanaka K, Deli MA, Yatsuhashi H, Niwa M.

Microvasc Res. 2014 Mar;92:41-9. doi: 10.1016/j.mvr.2013.12.004. Epub 2013 Dec 23.

PMID:
24370951
11.

Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model.

Toyoda K, Tanaka K, Nakagawa S, Thuy DH, Ujifuku K, Kamada K, Hayashi K, Matsuo T, Nagata I, Niwa M.

Cell Mol Neurobiol. 2013 May;33(4):489-501. doi: 10.1007/s10571-013-9913-z. Epub 2013 Feb 6.

PMID:
23385422
12.

Cilostazol strengthens barrier integrity in brain endothelial cells.

Horai S, Nakagawa S, Tanaka K, Morofuji Y, Couraud PO, Deli MA, Ozawa M, Niwa M.

Cell Mol Neurobiol. 2013 Mar;33(2):291-307. doi: 10.1007/s10571-012-9896-1. Epub 2012 Dec 7.

PMID:
23224787
13.

Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.

Hellinger E, Veszelka S, Tóth AE, Walter F, Kittel A, Bakk ML, Tihanyi K, Háda V, Nakagawa S, Duy TD, Niwa M, Deli MA, Vastag M.

Eur J Pharm Biopharm. 2012 Oct;82(2):340-51. doi: 10.1016/j.ejpb.2012.07.020. Epub 2012 Aug 11.

PMID:
22906709
14.

Activation of dorsolateral prefrontal cortex in a dual neuropsychological screening test: an fMRI approach.

Tachibana A, Noah JA, Bronner S, Ono Y, Hirano Y, Niwa M, Watanabe K, Onozuka M.

Behav Brain Funct. 2012 May 28;8:26. doi: 10.1186/1744-9081-8-26.

15.

Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats.

Nozaki Y, Kumagai K, Miyata N, Niwa M.

Acta Orthop. 2012 Feb;83(1):87-92. doi: 10.3109/17453674.2011.641103.

16.

Patented in vitro blood-brain barrier models in CNS drug discovery.

Tóth A, Veszelka S, Nakagawa S, Niwa M, Deli MA.

Recent Pat CNS Drug Discov. 2011 May 1;6(2):107-18. Review.

PMID:
21585327
17.

Lercanidipine rescues hippocampus pyramidal neurons from mild ischemia-induced delayed neuronal death in SHRSP.

Sakurai-Yamashita Y, Harada N, Niwa M.

Cell Mol Neurobiol. 2011 May;31(4):561-7. doi: 10.1007/s10571-011-9649-6. Epub 2011 Jan 23.

PMID:
21259046
18.

Pentosan reduces osteonecrosis of femoral head in SHRSP.

Miyata N, Kumagai K, Osaki M, Murata M, Tomita M, Hozumi A, Nozaki Y, Niwa M.

Clin Exp Hypertens. 2010;32(8):511-6. doi: 10.3109/10641963.2010.496511.

PMID:
21091356
19.

Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.

Nagai J, Uchida H, Matsushita Y, Yano R, Ueda M, Niwa M, Aoki J, Chun J, Ueda H.

Mol Pain. 2010 Nov 9;6:78. doi: 10.1186/1744-8069-6-78.

20.

Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity.

Deli MA, Veszelka S, Csiszár B, Tóth A, Kittel A, Csete M, Sipos A, Szalai A, Fülöp L, Penke B, Abrahám CS, Niwa M.

J Alzheimers Dis. 2010;22(3):777-94. doi: 10.3233/JAD-2010-100759.

PMID:
20847411

Supplemental Content

Loading ...
Support Center